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Chronic Hypoxemia in Late Gestation Decreases Cardiomyocyte
Number but Does Not Change Expression of Hypoxia-Responsive
Genes
Kimberley J. Botting, PhD; I. Caroline McMillen, MD, PhD; Heather Forbes, BPharm; Jens R. Nyengaard, MD, PhD; Janna L. Morrison, MSc, PhD
Background-—Placental insufﬁciency is the leading cause of intrauterine growth restriction in the developed world and results in
chronic hypoxemia in the fetus. Oxygen is essential for fetal heart development, but a hypoxemic environment in utero can
permanently alter development of cardiomyocytes. The present study aimed to investigate the effect of placental restriction and
chronic hypoxemia on total number of cardiomyocytes, cardiomyocyte apoptosis, total length of coronary capillaries, and
expression of genes regulated by hypoxia.
Methods and Results-—We induced experimental placental restriction from conception, which resulted in fetal growth restriction
and chronic hypoxemia. Fetal hearts in the placental restriction group had fewer cardiomyocytes, but interestingly, there was no
difference in the percentage of apoptotic cardiomyocytes; the abundance of the transcription factor that mediates hypoxia-induced
apoptosis, p53; or expression of apoptotic genes Bax and Bcl2. Likewise, there was no difference in the abundance of autophagy
regulator beclin 1 or expression of autophagic genes BECN1, BNIP3, LAMP1, and MAP1LC3B. Furthermore, fetuses exposed to
normoxemia (control) or chronic hypoxemia (placental restriction) had similar mRNA expression of a suite of hypoxia-inducible
factor target genes, which are essential for angiogenesis (VEGF, Flt1, Ang1, Ang2, and Tie2), vasodilation (iNOS and Adm), and
glycolysis (GLUT1 and GLUT3). In addition, there was no change in the expression of PKC-e, a cardioprotective gene with
transcription regulated by hypoxia in a manner independent of hypoxia-inducible factors. There was an increased capillary length
density but no difference in the total length of capillaries in the hearts of the chronically hypoxemic fetuses.
Conclusion-—The lack of upregulation of hypoxia target genes in response to chronic hypoxemia in the fetal heart in late gestation
may be due to a decrease in the number of cardiomyocytes (decreased oxygen demand) and the maintenance of the total length of
capillaries. Consequently, these adaptive responses in the fetal heart may maintain a normal oxygen tension within the
cardiomyocyte of the chronically hypoxemic fetus in late gestation. ( J Am Heart Assoc. 2014;3:e000531 doi: 10.1161/
JAHA.113.000531)
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H ypoxia during early fetal life is essential for normal heartgrowth, especially for embryonic outﬂow track remod-
eling1 and coronary vessel growth.2 Oxygen homeostasis is
tightly regulated by hypoxia-inducible factors (HIFs) within
fetal tissues. During acute hypoxia, HIFs recruit mechanisms
to increase oxygen supply (erythropoesis, angiogenesis, and
vasodilation), decrease oxygen demand (increased glycolysis
coupled with decreased oxidative metabolism), and regulate
the cell cycle, apoptosis, and autophagy (for review, see
Semenza3). HIFs function in a heterodimeric complex con-
sisting of an oxygen-regulated a isoform (HIF-1a, HIF-2a or
HIF-3a) and a constitutively expressed b isoform. Together,
HIFs act as a transcription factor that binds to a hypoxia
response element upstream of the promoter of genes
required for the response to cellular hypoxia. The degradation
of HIF-a subunits is oxygen dependent because prolyl
hydroxylases (prolyl hydroxylase domains [PHDs] 1 to 3)
require oxygen as a cosubstrate. During acute hypoxia, PHDs
cannot hydroxylate HIF-a, leading to increased HIF-a protein
stability and translocation to the nucleus, whereupon they
form a heterodimer with HIF-1b and recruit coactivators CREB
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binding protein and p300 to induce gene transcription (for
review, see Kaelin and Ratcliffe4). In addition, the stabilization
of HIF-1a protein also directly stabilizes and causes the
accumulation of tumor suppressor p53 protein,5 a transcrip-
tion factor that regulates cell cycle activity and apoptosis,
thus mediating hypoxia-induced apoptosis.
A lower-than-normal oxygen supply in utero can result in
lifelong consequences.6 Exposure to chronic hypoxemia in
utero results in intrauterine growth restriction and low birth
weight.7 A series of worldwide epidemiological studies have
demonstrated that low birth weight is a predictor of ischemic
heart disease and heart failure in adulthood, and this
association is supported by studies in a variety of animal
models of fetal hypoxemia (for review, see McMillen and
Robinson8). The cardiomyocytes present at birth constitute
the majority of the cardiomyocytes that an individual will have
for a lifetime9; therefore, considerable focus has been placed
on understanding the impact of reduced oxygen in utero on
cardiomyocyte development.
Chronic hypoxemia in the fetus can have different effects
on cardiomyocyte development depending on the timing in
relation to cardiac development and duration and degree of
the insult.10 In this context, “chronic” has been used to deﬁne
periods of exposure to hypoxia for periods ranging from
24 hours to several weeks. Interpretation of experimental
studies on the impact of fetal hypoxemia is further compli-
cated by the fact that exposure to hypoxemia for 1 week
constitutes one-third of gestation in rats but only 5% of
gestation in sheep and less in humans. Maternal hypoxia
during the last week of gestation in rats increases cardio-
myocyte apoptosis and accelerates cardiomyocyte matura-
tion.11 In adulthood, these rats have an increased
susceptibility to ischemia-reperfusion injury,12 which is partly
due to decreased expression of cardioprotective protein
kinase C-e (PKCe).13 Interestingly, the hypoxia induced
decrease in PKCe mRNA expression is independent of HIFs;
instead, it is mediated by intracellular reactive oxygen
species.14 Unlike humans, however, rats are born with an
immature cardiovascular system, with all cardiomyocytes
capable of proliferating.15 Terminally differentiated human
cardiomyocytes, in the form of binucleated cardiomyocytes,
have been observed at 0.8 of gestation, which is similar to
sheep, where binucleation begins at 0.7 of gestation (for
review, see Botting et al16). Studies of placental insufﬁciency
in sheep, which results in chronic fetal hypoxemia, hypogly-
cemia, and low birth weight, report altered fetal heart growth
in late gestation.17–19 Placental insufﬁciency, induced by the
removal of maternal endometrial caruncles prior to concep-
tion (long-term model of placental restriction [PR])19,20 or for
20 days in late gestation due to umbilicoplacental emboliza-
tion,17,18 causes a delay in the transition of proliferating
mononucleated cardiomyocytes to terminally differentiated
binucleated cardiomyocytes. In the PR model, chronic hypox-
emia occurs for at least the last 40 days of gestation (earliest
recording of fetal PaO2 in the PR model is 102 days of
gestation;20 term: 150 days), and despite both PR and
umbilicoplacental embolization fetuses being exposed to
chronic hypoxemia in late gestation, only umbilicoplacental
embolization fetuses, which are exposed to hypoxemia for
20 days, have a decreased percentage of mononucleated
cardiomyocytes undergoing proliferation.18,19 Interestingly,
the reverse is true for cardiomyocyte size, for which chronic
hypoxemia for the last 40 days of gestation results in
cardiomyocytes that are larger than expected for the size of
the heart,19 but chronic hypoxemia for up to 20 days in late
gestation does not.18 This hypertrophy persists into postnatal
life and is associated with an increased abundance of cardiac
growth factor IGF2R.21
We hypothesize that the increase in relative cardiomyocyte
size reﬂects a decrease in the endowment of cardiomyocytes
in late gestation. Because PR fetuses have an equivalent
percentage of proliferative cardiomyoctes in late gestation,19
we further hypothesis that PR fetuses will have greater
cardiomyocyte apoptosis mediated by hypoxia in addition to a
greater length of coronary capillaries and increased expres-
sion of genes that are unregulated in these processes in
response to acute hypoxia.
Methods
Animals and Surgical Procedures
All procedures were approved by the University of South
Australia and the University of Adelaide animal ethics
committees. In total, 32 control and 22 PR fetuses were
used in this study. PR was induced by performing a
carunclectomy in nonpregnant ewes, whereby the majority
of the endometrial caruncles were removed from the uterus
prior to conception.19 All surgery was performed under
aseptic conditions with general anesthesia induced by sodium
thiopentone (1.25 g/mL, intravenous; Boehringer Ingelheim)
and maintained with 3% to 4% halothane in oxygen. At
surgery, antibiotics were administered to the ewe (153.5 mg
procaine penicillin, 393 mg benzathine penicillin, 500 mg
dihydrostreptomycin; Lyppards). Ewes recovered from surgery
for >12 weeks prior to entering a mating program.
Vascular surgery was performed at 1191 days of gesta-
tion with general anesthesia induced by sodium thiopentone
(Pentothal; 1.25 g; Rhone Merieux) and maintained by
inhalation of halothane (2.5% to 4%) in oxygen, as described
previously.19 Brieﬂy, vascular catheters (Critchley Electrical
Products) were inserted in the maternal jugular vein, the fetal
carotid artery and jugular vein, and the amniotic cavity. Fetal
catheters were exteriorized through a small incision in the
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ewe’s ﬂank. Ewes were administered antibiotics during
surgery and for 3 days after surgery (as above, intramuscu-
larly). Fetuses were administered antibiotics during surgery
(intramuscularly; 150 mg procaine penicillin, 112.5 mg
benzathine penicillin, 250 mg dihydrostreptomycin; Lyppards)
and for 4 days after surgery (intra-amniotically; 500 mg
ibimicyn; GenePharm).
Arterial Blood Gas Measurements
Fetal carotid artery blood samples were collected daily to
monitor fetal health by measuring blood gases (PaO2, PaCO2,
oxygen saturation, pH, hemoglobin, and arterial oxygen
content19) at 39°C with an ABL 520 analyzer (Radiometer).
Animals recovered for 4 days postoperatively before blood
samples were recorded for experimental comparisons.
Tissue Collection
At 1401 days of gestation, ewes and fetuses were
humanely killed with an overdose of sodium pentobarbital
(8.2 g; Vibrac Aus), and fetuses were delivered by hysterot-
omy, weighed, and exsanguinated. The fetal heart was
dissected and weighed. Because the experimental aims of
this study required the heart to be processed in different
ways, the right ventricle (RV) was dissected, weighed, and
stored in 4% formaldehyde to determine the total number of
cardiomyocytes and capillary length density (control, n=8; PR,
n=5); frozen for gene analysis (control, n=9; PR n=8); or
enzymatically digested using a reverse Langendorff apparatus,
as previously described,19 to determine the average number
of nuclei per cardiomyocyte (control, n=14; PR, n=7) and the
percentage of apoptotic cardiomyocytes (control, n=6; PR,
n=6). The left ventricle (LV) was dissected and weighed, and a
piece was frozen for gene and protein analysis (control, n=15;
PR, n=12).
Total Number of Cardiomyocytes and Capillary
Length Density
The estimation of total cardiomyocyte number and capillary
length were performed using design-unbiased stereological
techniques.22
Tissue sampling
RV samples were ﬁxed in 4% formaldehyde and serially
sectioned into 2-mm slices. Using the smooth fractionator
principle,23 5 to 6 slices were selected and further cut to
create cubes of ≤2 mm3. Using the same principle, tissue
cubes were divided into groups of 8 to 12, with 1 group
embedded in glycolmethacrylate (Technovit 7100; Axlab) for
cardiomyocyte-number estimation and the other group
becoming isotropic with the isector24 and embedded in
parafﬁn for capillary length analysis.
Cardiomyocyte number estimation
The average number of nuclei per cardiomyocyte (NN(nuclei/
cm)) was determined from isolated cardiomyocytes from the
RV using Equation 1. Brieﬂy, isolated cardiomyocytes were
stained with methylene blue to visualize cardiomyocyte nuclei.
The number of mononucleated (ΣQ(mono)) and binucleated







The numerical density of cardiomyocyte nuclei was deter-
mined using the optical disector technique on glycol meth-
acrylate–embedded sections.25 From the center of each
glycol methacrylate block, a 30-lm-thick section was cut and
mounted on Superfrost Plus slides (Menzel-Gl€aser). To
visualize cardiomyocyte nuclei, sections were stained with
Mayer’s hematoxylin and 0.15% basic fuchsin. Point counting
was performed in about 20 two-dimensional unbiased count-
ing frames of surface area 500 lm2, which were systematic,
uniformly, randomly assigned by newCAST software (Visiop-
harm) to each ventricle piece. A disector height 10 lm in the
center of each section determined after a z-axis analysis was
used to determine the numerical density of nuclei in a
minimum of 6 ventricle pieces per animal. The numerical
density of nuclei in the RV (NV(nuclei/rv)) was determined
using Equation 2, in which ΣQ(nuc) is the number of nuclei,
h is the Z height analyzed, a/p is the area of ventricle that






The number of cardiomyocytes in the RV (N(cm,rv)) was
determined by dividing the NV(nuclei/rv) by the average
number of nuclei per cardiomyocyte and multiplying by the
volume of the RV (volume of RV equals postmortem wet
weight divided by 1.06 g/cm3).26
Length density and total length of capillaries
The length density of coronary capillaries in the RV (Lv(cap/
rv)) was determined in 5-lm-thick parafﬁn sections on
Superfrost Plus slides. Nonspeciﬁc antibody binding was
blocked by 1% bovine serum albumin (0.2% gelatin, 0.05%
saponin in phosphate-buffered saline). The primary antibody
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anti-a-smooth muscle actin (1:4000; A2547; Sigma-Aldrich)
was used to identify pericytes that wrap around the
endothelial cells of capillaries. Primary and secondary
antibody anti-mouse-HRP (1:200; 7076; Cell Signaling) were
diluted in phosphate-buffered saline containing 0.1% bovine
serum albumin and 0.3% Triton X. Antigen location was
visualized with 3,30-diaminobenzidine tetrahydrochloride
(4170; Kem-en-tec Diagnostics), and nuclei were visualized
with Mayer’s hematoxylin.
Capillaries were visualized at a magniﬁcation of 9600 with
a BX53 microscope (Olympus) equipped with a motorized
stage (ProScanIII Motorized Stage Systems; Prior) and digital
camera (DP72; Olympus). Point counting was performed in
about 20 two-dimensional unbiased counting frames of
surface area 10 000 lm2, which were uniformly randomly
assigned by newCAST software (Visiopharm) to each ventricle
piece. Lv(cap/rv) was calculated using Equation 3,
26 in which






The total length of capillaries in the RV (L(cap,rv)) was
calculated by multiplying the Lv(cap/rv) by the volume of
the RV.
Transferase dUTP Nick-End Labeling
Apoptosis was measured by the presence of DNA fragmenta-
tion with terminal deoxynucleotidyl transferase dUTP nick-end
labeling (Invitrogen) and visualized with 3,30-diaminobenzidine
tetrahydrochloride (metal-enhanced DAB substrate kit;
Thermo-Fischer Scientiﬁc). Isolated, paraformaldehyde-ﬁxed
cardiomyocytes from the RV were dried onto polylysine-coated
Superfrost Plus slides and ﬁxed with acetone. Positive control
slides were generated by inducing DNA nicks with DNAse I
(AMPD1; Sigma-Aldrich), and negative control slides were
generated by the absence of either terminal deoxynucleotidyl
transferase or nucleotides. The percentage of apoptotic
cardiomyocytes was determined by the presence of positive
terminal deoxynucleotidyl transferase dUTP nick-end labeling
staining in at least 1 nuclei of 200 mononucleated and 200
binucleated cardiomyocytes.
Measurement of mRNA Expression
RNA was isolated from the LV and RV (100 mg) of each fetus,
and cDNA was synthesized as described previously.21 Controls
containing no Superscript III and no RNA transcript were used
to test for genomic DNA and reagent contamination, respec-
tively. The reference genes tyrosine 3-monooxygenase (YW-
HAZ), glyceraldehyde-3-phosphate dehydrogenase (GAPDH),27
and phosphoglycerate kinase 1 (PGK1)27 were chosen from a
suite of reference genes based on expression analysis using
the geNorm component of the qBase relative quantiﬁcation
analysis software28 because their expression was stable
across samples.29 The expression of target and reference
mRNA transcripts were measured by quantitative reverse-
transcription polymerase chain reaction using Fast SYBR
Green Master Mix (Applied Biosystems) in a ﬁnal volume of
6 lL on a ViiA 7 Fast Real-Time PCR system (Applied
Biosystems), as described previously.29
Primers were validated to generate a single transcript, as
conﬁrmed by the presence of one double-stranded DNA
product of the correct size and sequence (Table 1). Controls
containing no cDNA were included for each primer set on
each plate to test for reagent contamination. Melt curve and
dissociation curves were also run to check for nonspeciﬁc
product formation. Ampliﬁcation efﬁciency reactions were
performed on 5 triplicate serial dilutions of cDNA template for
each primer set. Ampliﬁcation efﬁciencies were determined
from the slope of a plot of Ct (deﬁned as the threshold cycle
with the lowest signiﬁcant increase in ﬂuorescence) against
the log of the cDNA template concentration (1 to 100 ng).
The ampliﬁcation efﬁciency was close to 100%. Each sample
was run in triplicate for target and reference genes. The
reactions were quantiﬁed by setting the threshold within
the exponential growth phase of the ampliﬁcation curve and
obtaining corresponding Ct values. The abundance of each
transcript relative to the abundance of the 3 stable reference
genes was calculated using DataAssist software version 3.0
(Applied Biosystems) and expressed as mean normalized
expression.28
Quantiﬁcation of Protein Abundance by Western
Blot
Proteins were extracted from the LV by sonication in lysis buffer
(50 mmol/L Tris-HCL [pH 8], 150 mmol/L NaCl, 1% NP-40,
1 mmol/L Na orthovanadate, 30 mmol/L Na ﬂuoride,
10 mmol/L Na pyrophosphate, 10 mmol/L EDTA, and a
protease inhibitor tablet [cOmplete Mini; Roche]). Total protein
concentration was determined by Micro BCA assay (Thermo-
Fisher Scientiﬁc). Protein was diluted to a concentration of
5 mg/mL in 19 sodium dodecyl sulfate sample buffer
(containing 75 mmol/L DL-Dithiothreitol) and Coomassie blue
stain used to conﬁrm equal protein loading on sodium dodecyl
sulfate polyacrylamide gel electrophoresis before diluted
protein was used for experimental blots. Proteins were
transferred to a nitrocellulose membrane (Amersham Hybond-
C extra; GE Healthcare Life Sciences) using boric acid transfer
buffer. Nonspeciﬁc antibody binding was blocked with 5% skim
milk in Tris-buffered saline with 1% Tween-20 or 5% bovine
serum albumin in Tris-buffered saline with 1% Tween-20.
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Table 1. Primer Sequences Used in Quantitative Reverse Transcription Polymerase Chain Reaction to Measure Genes of Interest
Gene Primers Accession Number
Tyrosine 3-monooxygenase (YWAHZ; reference gene) Fwd 50-CCTGGAGAAACCTGCCAAGT-30 AY970970
Rev 50-GCCAAATTCATTGTCGTACCA-30




Phosphoglycerate kinase 1 (PGK1; reference gene) Fwd 50-ACTCCTTGCAGCCAGTTGCT-30 NM_001034299
Rev 50-AGCACAAGCCTTCTCCACTTCT-30
Beclin 1 (BECN1) Fwd 50- GAACCTCAGCCGAAGACTAAAG-30 XM_004012945.1
Rev 50-CTAAGAGGGTGTCTGTGCATTC-30
BCL2/adenovirus E1B 19 kDa interacting protein 3 (BNIP3) Fwd 50-GTTCCCGACTCTGCTTCTATTT-30 XM_004020372.1
Rev 50-GTCACAGTGGGAGCTCTTG-30
Lysosomal-associated membrane protein 1 (LAMP1) Fwd 50-CTTGAGAGCTGGCACTTAGAA-30 XM_004012369.1
Rev 50-CTCCAACAGGAAACGGAGAA -30
Microtubule-associated protein 1 light chain 3b (MAP1LC3B) Fwd 50-ACGCTCCTTGAGAGGATCTA-30 NM_022818
Rev 50-CAGCAGCATGGTTTCCTTATTT-30
Hypoxia-inducible factor 1a (HIF-1a) Fwd 50-TGAGCTTGCTCATCAGTTGCCA-30 AY485676.1
Rev 50-ACGCAAATAGCTGATGGTGAGCCT-30
Hypoxia-inducible factor 2a (HIF-2a) Fwd 50-TACAGGTTCCTCCCCGTCAC-30 NM_174725.2
Rev 50-CTTGTCAGCTGTCATTGTCGC-30
Hypoxia-inducible factor 3a (HIF-3a) Fwd 50-GTGGAGTTCCTGGGCATCAG-30 EU340262.1
Rev 50-CCCGTCAGAAGGAAGCTCAG-30
Hypoxia-inducible factor 1b (HIF-1b) Fwd 50-AGGTGTGGCAATAGCTCTGTGGAT-30 NM_173993.1
Rev 50-AGGCCTTGATATAGCCTGTGCAGT-30
Vascular endothelial growth factor A (VEGFA) Fwd 50-TGTAATGACGAAAGTCTGGAG-30 AF071015.1
Rev 50-TCACCGCCTCGGCTTGTCACA-30
VEGF receptor 1 (Flt1) Fwd 50-CCGAAGGGAAGAAGGTGGTC-30 NM_001191132.2
Rev 50-GACTGTTGTCTCGCAGGTCA-30
Angiopoietin 1 (ANGPT1; Ang1) Fwd 50-TGCAAATGTGCCCTCATGCT-30 AY881028.1
Rev 50-TTCCATGGTTCTGTCCCGCT-30
Angiopoietin 2 (ANGPT2; Ang2) Fwd 50-AGAACCAGACCGCTGTGATG-30 AY881029.1
Rev 50-TGCAGTTTGCTTATTTCACTGGT-30
Tyrosine-protein kinase receptor (TEK/Tie2) Fwd 50-CAGTTTACCAGGTGGACATC-30 AY288926.1
Rev 50-ACATTTTGGAAGGCTTGGGC-30








Inducible nitric oxide synthase (iNOS) Fwd 50-AAGGCAGCCTGTGAGACATT-30 AF223942.1
Rev 50-CAGATTCTGCTGCGATTTGA-30
Adrenomedullin (Adm) Fwd 50-GGGGTGCAAGCCTCACTATT-30 NM_173888.3
Rev 50- CACATTCCACGCAGCAAACA-30
B-cell CLL/lymphoma 2 (Bcl2) Fwd 50-GTGGAGGAGCTCTTCAGGGA-30 HM630309.1
Rev 50-GTTGACGCTCTCCACACACA-30
Continued
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Primary antibodies anti-p53 (1:200, mouse monoclonal anti-
body, OP104L; Merck), anti-PHD1 (1:500, rabbit polyclonal
antibody, NB100-310; Novus Biological) and anti-PHD2 (1:500,
rabbit polyclonal antibody, NB100-137; Novus Biological) were
incubated overnight. Secondary antibodies mouse-HRP
(1:2000, 7075; Cell Signaling) and rabbit-HRP (1:2000, 7076;
Cell Signaling) were incubated for 1 hour at room temperature.
SuperSignal West Pico chemiluminescent substrate (Thermo-
Fisher Scientiﬁc) and an ImageQuant LAS 4000 (GE Healthcare)
were used to detect and image antigens of interest. Image-
QuantTL Analysis Toolbox (GE Healthcare) was used to quantify
the protein bands, and the ratio of band density from 50% and
100% of the loading control constituted from an equal amount
of protein extracts from each animal was used to ensure
linearity of density measurement. Each antibody was repeated
on new blots to ensure reproducibility of results.
Statistical Analyses
Fetuses were included in the control group if the ewe did not
undergo carunclectomy surgery and if they had a mean
gestational PaO2 >17 mm Hg; fetuses were included in the
PR group if they were chronically hypoxemic, deﬁned as a
mean gestational PaO2 <17 mm Hg.
19,30 Because some twin
pregnancies (11 of 22 pregnancies in the control group; 8 of
19 pregnancies in the PR group) were included in this study, a
2-way analysis of variance for the effect of treatment group
and fetal number, nested for litter, was used, and there was
no statistical interaction between treatment and fetal number
for any parameters measured in this study. Pearson correla-
tion and linear regression analysis were used to determine the
relationship between the total number of cardiomyocytes in
the RV and either fetal weight or the length of coronary
capillaries. A probability level of 5% (P<0.05) was considered
signiﬁcant. Box plots were used instead of bar graphs to
describe the distribution of data.
Results
Arterial Blood Gas and Fetal Weight
Measurements
PR resulted in reduced PaO2, oxygen saturation, and arterial
oxygen content but did not alter the concentration of
hemoglobin compared with controls (Table 2). PR and control
fetuses had equivalent PaCO2 and base excess, but PR
fetuses had lower pH, although they were not clinically
acidotic (Table 2). Fetuses exposed to chronic hypoxemia had
reduced body and asymmetric growth, represented by
increased brain weight relative to body weight. Chronically
hypoxemic fetuses had smaller hearts but maintained heart
weight relative to body weight in late gestation compared with
controls (Table 3).
Cardiomyocyte Endowment, Apoptosis, and
Autophagy
Fetuses exposed to chronic hypoxemia had a decreased total
number of cardiomyocytes and binucleated cardiomyocytes
Table 1. Continued
Gene Primers Accession Number
Bcl-2 associated protein (Bax) Fwd 50-CAGGATGCATCCACCAAGAAGC-30 AF163774.1
Rev 50-TTGAAGTTGCCGTCGGAAAACATT-30
Protein kinase C-e (PKCe) Fwd 50-AGCACCCGTTCTTCAAGGAG-30 XM_004005978.1
Rev 50-TGCTTGCAGCATCACCAAAC-30
Egl nine homolog 2 (EGLN2/PHD-1) Fwd 50-ATGGTGGCATGTTACCCAGG-30 NM_001102193.1
Rev 50-AGGGGCTCAATGTTGGCTAC-30
Egl nine homolog 1 (EGLN1/PHD2) Fwd 50-TGGAGATGGAAGATGTGTGA-30 NM_001206046.2
Rev 50-TTGGGTTCAATGTCAGCAAA-30
Egl nine homolog 3 (EGLN3/PHD3) Fwd 50-TGCTACCCAGGAAATGGAACAGGT-30 NM_001101164.1
Rev 50-GCTTGGCATCCCAGTTCTTGTTCA-30
Table 2. Fetal Arterial Blood Gas Measurements
Control PR
PaO2 on day of postmortem, mm Hg 20.80.7 12.70.5*
Mean gestational PaO2, mm Hg 21.90.5 13.70.4*
Mean gestational O2 saturation, % 65.81.7 37.51.7*
Mean gestational hemoglobin, g/dL 10.50.22 11.30.61
Mean gestational O2 content, mL/dL 9.60.2 5.80.3*
Mean gestational PaCO2, mm Hg 49.20.6 50.41.2
Mean gestational pH 7.3840.005 7.3690.005*
Mean gestational base excess, mEq/L 2.80.3 3.50.5
Values are meanSEM (SD). PR indicates placental restriction.
*P<0.05.
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in the RV (Figure 1A through 1C). The total number of
cardiomyocytes in the RV was positively associated with
fetal body weight (regression analysis: P<0.001; R2=0.968;
y=1.950.70x+0.17x2; Figure 1D). Despite reduction in
the total number of cardiomyocytes, there was no effect of
exposure to chronic hypoxemia on the percentage of
apoptotic cardiomyocytes or the mRNA expression of the
anti-apoptotic gene B-cell CLL/lymphoma 2 (Bcl2) or the pro-
apoptotic gene Bcl2 associated protein (Bax). RV (Figure 2A
through 2C). Furthermore, fetuses exposed to chronic
hypoxemia had an equivalent abundance of p53 protein in
the LV (Figure 2D), which is responsible for hypoxia-induced
apoptosis. Paradoxically, fetuses exposed to chronic hypox-
emia had a decrease in mRNA expression of pro-apoptotic
Bax; however, there was also a decrease in the mRNA
expression of antiapoptotic Bcl-2 in the LV (Figure 2E and
2F). Furthermore, exposure to chronic hypoxemia did not
alter the expression of autophagic genes Beclin-1 (BECN1),
BCL2/adenovirus E1B 19kDa interacting protein 3 (BNIP3),
Lysosomal-associated membrane protein 1 (LAMP1) or
Microtubule-associated protein 1 light chain 3 beta
(MAP1LC3B) or the abundance of Beclin-1 protein (Table 4).
Expression of HIFs and Hypoxia Mediated Genes
There was no difference in the mRNA expression of HIF-1a,
HIF-2a, HIF-3a, and HIF-1b and genes with hypoxia response
elements that are involved in angiogenesis (Vascular
endothelial growth factor [VEGF], VEGF Receptor 1 [Flt1],
Angiopoietin-2 [Ang2] and Tyrosine-protein kinase receptor
[Tie2]), vascular tone (Inducible nitric oxide synthase [iNOS]),
and glysolysis (Solute carrier family 2 (facilitated glucose
transporter), member 1 [GLUT1] and member 3 [GLUT3]). or
in the hypoxia-regulated cardioprotective gene Protein kinase
C-e (PKCe) in either the LV or the RV of fetuses exposed
to chronic hypoxemia compared with controls (Table 5).
Table 3. Fetal Body and Heart Weight Measurements
Control PR
Fetal weight, kg 4.680.12 2.520.16*
Heart weight, g 32.170.79 18.770.81*
Relative heart weight, g/kg 6.710.09 7.120.19
Relative brain weight, g/kg 12.750.37 19.770.88*




Figure 1. Placental restriction (PR) resulting in chronic hypoxemia reduced the total number of
cardiomyocytes (A) and binucleated cardiomyocytes (C) but not mononucleated cardiomyocytes (B) in the
right ventricle. The total number of cardiomyocytes is positively correlated with fetal weight (D). *P<0.05;
Control, ○; PR, ●.
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Fetuses exposed to chronic hypoxemia had a decrease in the
mRNA expression of the angiogenic gene Ang1 and the
vasoactive gene Adrenomedullin (Adm) in the LV, but there
was no change in the RV.
Length of Coronary Capillaries
Fetuses exposed to chronic hypoxemia had an increased
capillary length density (Figure 3A) but a similar total length
of capillaries in the RV compared with controls (Figure 3B).
Interestingly, control fetuses maintained a positive relation-
ship between the number of cardiomyocytes and the length of
capillaries (y=4.55+3.68x; Figure 3C), but PR fetuses did
not. A similar length of capillaries with a reduction in the
number of cardiomyocytes would indicate that there was a
greater length of capillaries per cardiomyocyte in the RV of
the PR fetus (Figure 3D).
Expression and Abundance of HIF Regulators,
PHDs
Exposure to chronic hypoxemia resulted in increased mRNA
expression of the HIF destabilizing gene PHD3 but only in
the LV (Table 5), coupled with an increased abundance of
PHD2 protein (Figure 4). There was no change in the mRNA
expression of PHD1 or PHD2 in either ventricle (Table 5).
Similarly, there was no change in the protein abundance of
PHD1 (Figure 4).
Discussion
In the present study, experimental induction of PR in the
sheep from conception resulted in chronic fetal hypoxemia,
reduced fetal growth, and fewer cardiomyocytes in the fetal
heart. This study is the ﬁrst to demonstrate that there is a
reduction in the total number of cardiomyocytes in a large
animal model of intrauterine growth restriction in which the
timing of cardiomyocyte maturation is similar to humans.
Consistent with the current ﬁndings, maternal protein
restriction in rats reduces fetal growth, heart weight, and
total number of cardiomyocytes at birth.31 Furthermore, rats
exposed to maternal hypoxia during the last week of
pregnancy may also have a lower number of cardiomyocytes
because adult offspring have the same heart weight as
controls but larger individual cardiomyocytes.32 A reduction in
the total number of cardiomyocytes may have critical
consequences for heart health in later life because at birth,
the hearts of both sheep and human contain the majority of
A B C
D E F
Figure 2. Placental restriction (PR) resulting in chronic hypoxemia did not alter the percentage of apoptotic cardiomyocytes (A) or the mRNA
expression of pro-apoptotic gene Bax (B) or antiapoptotic gene Bcl2 (C) in the right ventricle. PR did not affect the protein abundance of hypoxia-
mediated apoptosis regulator p53 (D) but resulted in decreased mRNA expression of both pro-apoptotic gene Bax (E) and antiapoptotic gene
Bcl2 (F) in the left ventricle. Open circle represents an outlier, deﬁned as being >1.59IQR; *P<0.05. MNE indicates mean normalized expression;
TUNEL, terminal deoxynucleotidyl transferase dUTP nick-end labeling.
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the cardiomyocytes they will have for life.9,33 Consequently,
the remaining cardiomyocytes will be required to increase in
size to increase their capacity for contractile force generation,
rendering the individual vulnerable to heart disease.34,35
This premise is supported by studies in the hypertrophic heart
rat model, which has a smaller body from 2 days of age and a
heart that contains smaller and fewer cardiomyocytes that
have prematurely exited the cell cycle,36 and these rats
develop cardiac hypertrophy in the absence of hypertension
by 2 months of age.37 Interestingly, in the present study, the
linear relationship between the number of cardiomyocytes
and fetal weight, as previously reported in sheep with
naturally occurring variations in birth weight,38 only holds
true for fetuses with a body weight >3 kg. It appears that
there may be a critical threshold for the number of
cardiomyocytes required to maintain function in fetuses
<3 kg. A reduction in cardiomyocyte endowment, as observed
in the present model of chronic hypoxemia and intrauterine
growth restriction, provides a potential link for the epidemi-
ological association between intrauterine growth restriction
and increased incidence of ischemic heart disease and heart
failure in adult life.
Maternal hypoxia from 15 to 21 days of gestation in rats
results in an increase in HIF-1a protein abundance in the fetal
heart at 21 days of gestation.11 Furthermore, fetal rats
exposed to maternal hypoxia had a greater percentage of
binucleated cardiomyocytes, which were also larger in size.
This is in contrast to previous studies in fetal sheep in which
hypoxemia due to umbilicoplacental embolization18 or PR19
not only reduced the percentage of binucleated cardiomyo-
cytes, PR also reduced their size.19 Furthermore, in contrast
to the present study, fetal rats exposed to maternal hypoxia
in the last week of gestation had a greater percentage of
terminal deoxynucleotidyl transferase dUTP nick-end labeling–
positive or apoptotic cardiomyocytes, possibly due to a
decrease in antiapoptotic Bcl2 protein abundance and an
increase in the pro-apoptotic protein Fas.11 In the present
study, chronic hypoxemia did not alter the mRNA expression
of the antiapoptotic gene Bcl2 or the pro-apoptotic gene Bax
in the RV, whereas in the LV, exposure to chronic hypoxemia
decreased the mRNA expression of Bcl2 and Bax. A decrease
in both anti- and pro-apoptotic factors may suggest that there
is a similar Bcl2:Bax ratio, an index of mitochondrial-mediated
apoptosis, that is trigged when the ratio favors Bax.39
Although HIFs do not transcribe Bax, its expression can be
regulated by hypoxia due to an HIF-1a–dependent interaction
with the transcription factor p53.5,40 Tumor suppressor p53
protein is stabilized in response to cellular stressors, including
hypoxia,41 to arrest the cell cycle, induce apoptosis, and
regulate autophagy.42 Another important p53-43 and hypoxia-
induced44 regulator of cardiac cell death is BNIP3, which
encodes a pro-apoptotic Bcl2 family protein and can induce
apoptosis44 and necrosis45 and is linked to the induction of
autophagy in cardiac ischemia–reperfusion injury.46 Auto-
phagy is utilized to maintain cellular homeostasis both at
baseline and in response to stress, such as hypoxia.
Autophagy is also promoted by Beclin-1, which forms the
autophagasome and is encoded by the BECN1 gene. During
hypoxia, increased autophagy has been associated with
increased transcription of autophagy-related genes such as
BNIP3,47–49 BECN1,50 MAP1LC3B,49 and LAMP1.51
In the present study, chronic hypoxemia for at least the
last third of gestation in fetal sheep did not lead to increased
terminal deoxynucleotidyl transferase dUTP nick-end label-
ing–positive cardiomyocytes; an accumulation of p53
protein; an increase in Bax, BNIP3, BECN1, LAMP-1, or
MAP1LC3B transcription; or an increase in Beclin-1 abun-
dance. This suggests that in late gestation, the heart is not
experiencing greater apoptosis or autophagy and thus may
not be hypoxic.
Despite PR fetuses being hypoxemic in late gestation, we
did not observe an increase in the cardiac mRNA expression
Table 4. Expression of Markers of Autophagy
Left Ventricle Right Ventricle
Control PR Control PR
Gene
BECN1 0.0770.005 0.0710.006 0.0810.013 0.050.008
BNIP3 0.4380.040 0.4930.049 0.5410.115 0.3970.064
LAMP1 0.1540.012 0.1800.023 0.1720.039 0.0950.011
MAP1LC3B 0.0970.004 0.1030.009 0.1290.051 0.0670.010
Protein
Beclin 1 34.38.3 55.612.8
Values are meanSEM (SD). PR indicates placental restriction.
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of genes with hypoxia response elements, which are crucial
for a cell’s response to hypoxia to increase oxygen supply by
angiogenesis (VEGF, Flt1, Ang2, and Tie2) and vasodilatation
(iNOS and Adm) or to decrease oxygen demand by increasing
anaerobic metabolism (GLUT1 and GLUT3). It is possible that
this lack of change is due to the small sample size and a lack
of power or that the heart is not hypoxic at the time point we
studied. An alternative interpretation of the results presented
in this study is that chronic hypoxia is unable to upregulate
hypoxia-responsive processes due to the “desensitization”
and destabilization of HIF-a subunits. Ginouves and col-
leagues suggested that reduction in mitochondrial respiration
during hypoxia results in an increase in intracellular oxygen,
enabling PHDs to be active despite hypoxia.52 Mice exposed
to chronic hypoxia (24 hours; 8% oxygen in air) do not have
stabilized HIF-1a protein in the kidney, brain, and thymus,
despite HIF-1a being present after 6 hour of hypoxia
(acute).52 After acute hypoxia, there was a decrease in PHD
activity, which was reactivated after 24 hours of hypoxia.
Furthermore, silencing all PHDs using small interfering RNA
after 24 hours of hypoxia resulted in stabilization of HIF-1a
protein, providing evidence that it is PHD mediated. The
theory of HIF-1a desensitization is supported by studies in the
skeletal muscle of exercising mice exposed to 1 day of
hypobaric hypoxia (acute) during which HIF-1a protein was
stabilized versus 1 week of hypobaric hypoxia (chronic) during
which no HIF-1a protein was measured.53 In the present
study, chronic hypoxemia resulted in an increase in the mRNA
expression of PHD3 but only in the LV, as well as an increase
in the abundance of PHD-2 protein. The transcription of
PHD2 and PHD3 is regulated by HIFs, possibly to promote
rapid degradation of HIF-a once normoxia is achieved.
Table 5. mRNA Expression of HIFs, Genes With Hypoxia Response Elements, and Genes Involved in Cardioprotection and HIF-a
Stability
Left Ventricle Right Ventricle
Control PR Control PR
Gene
Oxygen sensing
Hif-1a 0.3900.035 0.3430.036 0.3480.022 0.2850.018
Hif-2a 0.3890.026 0.4990.083 0.4870.090 0.3870.047
Hif-3a 0.0730.010 0.0610.013 0.0650.006 0.0930.013
Hif-1b 0.0600.010 0.0490.008 0.0560.005 0.0760.010
Angiogenesis
VEGF 0.6110.054 0.6370.122 0.4360.076 0.6030.065
Flt-1 0.1020.009 0.1080.011 0.1150.006 0.1400.012
Ang-1 0.0180.002 0.0090.002* 0.0470.016 0.0190.004
Ang-2 0.0160.001 0.0150.003 0.0180.003 0.0210.002
Tie-2 0.0750.009 0.0550.011 0.0540.005 0.0850.014
Vasodilation
iNOS 0.0100.002 0.0060.001 0.0060.001 0.0070.001
Adm 0.0130.001 0.0090.001* 0.0070.001 0.0060.001
Glucose metabolism
GLUT1 0.0500.006 0.0560.010 0.0420.010 0.0530.009
GLUT3 1.0200.158 0.9310.072 1.3840.327 1.7290.271
Cardio-protection
PKCe 0.0530.006 0.0480.007 0.0720.011 0.0500.008
HIF-a stability
PHD1 0.0810.007 0.0770.006 0.0710.007 0.0720.009
PHD2 0.3910.026 0.3440.048 0.3790.029 0.4180.055
PHD3 0.2840.020 0.4500.047* 0.3400.036 0.4360.058
Values are meanSEM (SD). Adm indicates adrenomedullin; Ang, angiopoietin; GLUT, glucose transporter; HIF, hypoxia-inducible factor; iNOS, inducible nitric oxide synthase; PHD, prolyl
hydroxylases; PKCe, protein kinase C-epsilon; PR, placental restriction; VEGF, vascular endothelial growth factor.
*P<0.05.
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Consequently, the increase in PHDs and the absence of
increased transcription of hypoxia-responsive genes in our
study present different interpretations, either that the heart is
chronically hypoxic and HIF-1a has been desensitized or that
the heart is not hypoxic. Considering that we did not see a
difference in the mRNA expression of PKCe, for which
transcription due to prenatal hypoxia in cardiomyocytes is
inhibited by intracellular reactive oxygen species and is
independent of HIFs, the evidence suggests that the heart is
not hypoxic.13,14 This lack of transcriptional activation in the
heart of PR fetuses suggests that, despite exposure to chronic




Figure 3. Placental restriction (PR; A and F) resulting in chronic hypoxemia increased capillary length
density in the right ventricle compared with controls (A and E); however, there was a similar total length of
capillaries (B). In the control right ventricle, there was a signiﬁcant positive correlation between the total
number of cardiomyocytes and the total length of capillaries; however, this correlation was not present in
the PR group (C). Note, analysis of combined data from the control and PR groups demonstrated a
signiﬁcant correlation between the total length of capillaries and cardiomyocyte number (r=0.620,
P=0.042); however, simple/linear regression analysis failed to reach signiﬁcance. There is an increase in
the length of capillaries per cardiomyocyte in the PR group compared with the control group (D; presented
as arbitrary units (au) due to the 2 analyses being performed in sections embedded in different compounds;
control, n=7; PR, n=4; these numbers are reduced because not every animal had both components
analyzed). Coronary capillaries were identiﬁed with immunohistochemistry for a-smooth muscle actin in the
pericytes that surround the capillaries (brown) and counterstained with Mayer’s hematoxylin. An open circle
represents an outlier, deﬁned as being >1.59IQR; *P<0.05.
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potentially due to a lower demand for oxygen because it
contains fewer cardiomyocytes and they are smaller.19
Considering that there is also no difference reported in the
percentage of cardiomyocytes in the cell cycle,19 we suggest
that, earlier in gestation, there has been either a reduction in
the rate of proliferation (as observed in fetal sheep studies in
which hypoxemia has been present for up to 20 days)18 or an
increase in cardiomyocyte apoptosis (as observed in rat
offspring of maternal hypoxia in the last week of gestation)11
that has resulted in the reduced number of cardiomyocytes
observed in late gestation in the present study.
Considering that we did not observe a change in the mRNA
expression of the angiogenic genes VEGF, Flt1, Ang1, Ang2, or
Tie2 in the RV, it was surprising to observe an almost doubling of
capillary length density in the RV of the chronically hypoxemic
fetus. An increase in capillary density (angiogenesis) in
response to acute hypoxia has been well documented and is
essential to increased oxygen supply (for review, see Pugh and
Ratcliffe54). Interestingly, there was no difference in the total
length of capillaries in the RV of fetuses exposed to chronic
hypoxemia compared with controls, suggesting an increased
length of capillaries per cardiomyocyte. We speculate that
cardiomyocytes and capillaries are differentially sensitive to the
early environment in the PR fetus, and this ensures that each
cardiomyocyte may have normal oxygen tension.
Conclusion
In the present study, chronic hypoxemia for at least the last
third of gestation,20 resulted in growth-restricted fetuses with
smaller hearts that contained fewer cardiomyocytes. Despite
a reduction in the number of cardiomyocytes, there is no
difference in the percentage of terminal deoxynucleotidyl
transferase dUTP nick-end labeling–positive or apoptotic
cardiomyocytes or in the protein abundance of the hypoxia-
mediated apoptosis regulator p53. Furthermore, there was
neither a difference nor a decrease in the mRNA expression of
the pro-apoptotic gene Bax, the transcription of which is
typically upregulated during hypoxia by p53.40 In addition,
there was no change in the expression of autophagic genes
that have been previously associated with hypoxia-mediated
autophagy or in the protein abundance of a key regulator of
autophagy, Beclin-1, compared with controls. Interestingly,
there was no difference in the mRNA expression of HIFs (HIF-
1a, HIF-2a, HIF-3a, and HIF-1b) or target genes with hypoxia
response elements that are central to hypoxia-mediated
angiogenesis (VEGF, Flt1, Ang2, or Tie2), glycolysis (GLUT1 or
GLUT3), and vasodilation (iNOS and Adm). Furthermore, we
did not observe a decrease in the mRNA expression of PKCe,
for which transcriptional regulation due to prenatal hypoxia is
independent of HIFs. Despite chronic hypoxemia, PR fetuses
had a similar length of capillaries compared with controls,
suggesting an increased length of capillaries per cardiomyo-
cyte. These data suggest that in late gestation, the heart of
the chronically hypoxemic fetus is not experiencing cellular
hypoxia potentially due to a decrease in oxygen demand
(fewer and smaller cardiomyocytes) and an appropriate
oxygen supply (maintenance of the total length of capillaries
despite a smaller heart). This study suggests that the
adaptation to hypoxia occurs earlier in gestation.
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